Felix Sellberg

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Squamous Cell Carcinoma

Protein Protein

Immune Response

Radiation Therapy

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Karl Sandström, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson, Göran Laurell
Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma. International journal of molecular sciences 24 (4) (2023)
Felix Sellberg, Fanny Fredriksson, Thomas Engstrand, Tim Melander Bowden, Bo Nilsson, Jaan Hong, Folke Knutson, David Berglund
Polyvinylalcohol-carbazate (PVAC) reduces red blood cell hemolysis. PloS one 14 (12) (2019)